Lobbying

Alvogen, Pharma US's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Health Issues.

Alvogen, Pharma US

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Alvogen, Pharma US lobbying by quarter
Alvogen, Pharma US lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$30K1
Q2 2023$10K1
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$10K1
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Pharmacy$80K · 3 reports
  • Health issues$50K · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Hogan Lovells Cadwalader US$130K15 quarters

Former officials lobbying for it

Former position
AARON S. CUTLERSenior Policy Advisor, House Com. Nat. Resources, 2014; Snr. Advsr. for Policy and Outreach, Off. of House Maj. Leader Eric Cantor, 2013-2014; Dep. Pol. Director, Hse. Committee on Energy and Commerce, 2009-2013Q2 2025
CYBIL G. ROEHRENBECKLegislative Counsel to Office of Representative Walter B. Jones (2006 - 2010); Office of Representative J.C. Watts (2002)Q2 2025
CHARLES KOLO RATHBURNDirector of Legislative Affairs, U.S. Department of Commerce (2018-2019); Professional Staff Member, U.S. Senate Committee on Appropriations (2013-2018); Legislative Assistant, Office of U.S. Senator Roger F. Wicker (R-MS) (2011-2013); NOAA Sea GrQ2 2023
EDUARDO IVAN ZAPIENChief of Staff to US Senator Robert Menendez 2003-2008; National Outreach Director for the House Democratic Caucus 2002-2003Q2 2023
NORM COLEMANU.S. Senator (2003-2009)Q4 2022

Lobbying reports

Filed by
07/14for Q2Hogan Lovells Cadwalader USUnder $5,000
04/13for Q1Hogan Lovells Cadwalader USUnder $5,000
01/20for Q4 2025Hogan Lovells Cadwalader USUnder $5,000
25/10/17for Q3 2025Hogan Lovells Cadwalader USUnder $5,000
25/07/16for Q2 2025Hogan Lovells Cadwalader US$10K
25/04/15for Q1 2025Hogan Lovells Cadwalader US$20K
25/01/21for Q4 2024Hogan Lovells Cadwalader US$20K
24/10/14for Q3 2024Hogan Lovells Cadwalader USUnder $5,000
24/07/12for Q2 2024Hogan Lovells Cadwalader USUnder $5,000
24/04/11for Q1 2024Hogan Lovells Cadwalader USUnder $5,000
24/01/11for Q4 2023Hogan Lovells Cadwalader USUnder $5,000
23/10/16for Q3 2023Hogan Lovells Cadwalader USUnder $5,000
23/07/14for Q2 2023Hogan Lovells Cadwalader US$10K
23/04/13for Q1 2023Hogan Lovells Cadwalader US$30K
23/01/17for Q4 2022Hogan Lovells Cadwalader US$40K